Literature DB >> 11008118

The divergent role of tumor necrosis factor receptors in infectious diseases.

D Schlüter1, M Deckert.   

Abstract

Tumor necrosis factor (TNF) receptor types 1 and 2 are broadly expressed by most cell types and are activated by binding of either TNF or lymphotoxin-beta. TNF receptor-mediated immune reactions are critically important in the pathogenesis and control of a variety of infections caused by bacteria, viruses, protozoa, and fungi. This review summarizes recent findings on the role of TNF receptors in infectious diseases and discusses the divergent functions of these receptors in immune responses.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11008118     DOI： 10.1016/s1286-4579(00)01282-x

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  21 in total

1.  A role for CD36 in the regulation of dendritic cell function.

Authors:  B C Urban; N Willcox; D J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 2.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 3.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

4.  Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.

Authors:  Paul B Mann; Kelly D Elder; Mary J Kennett; Eric T Harvill
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.

Authors:  Siwei Nie; Markus Cornberg; Liisa K Selin
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

6.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 7.  Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors:  Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal:  Respir Med       Date:  2009-02-07       Impact factor: 3.415

8.  Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection.

Authors:  Thomas A Moore; Michelle L Perry; Andrew G Getsoian; Christine L Monteleon; Anna L Cogen; Theodore J Standiford
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.

Authors:  Michele F Rodrigues; Caio C S Alves; Bárbara B M Figueiredo; Alice B Rezende; Sabine Wohlres-Viana; Vânia Lúcia da Silva; Marco Antônio Machado; Henrique C Teixeira
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 10.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.